Untangle the Phenomics

qPharos™ Cutting-edge Technology

Leverage the AI algorithm and information exchange, utilize the proprietary isotope feature library, safeguard the full workflow analysis of complex phenotypes, revolutionize the discovery and absolute quantification of ultra-precise and standardized mass spectrometry testing, and trailblaze the path of phenomics exploration.

qULTRA® Precision
Omics Platform

Based on the qPharos™ technology, deeply revolutionize the entire workflow of sample preparation, data collection and data analysis, build a brand-new qULTRA® precision omics platform, and continuously produce phenomics data efficiently with unparalleled sensitivity, stability, and high throughput.

· Proprietary IP and barrier of core technologies

· Multi-center verification of 11 labs around the world

· Bridge the gap between research and translation application

qPharos™ Mass Spectrometry
Applicable sample types
Sample amounts
Proteomics
Post-Translation Modification
Metabolomics
Lipidomics
Depth of testing
Capability of testing
Quantitative Analysis
Specificity
Reproducibility(CV)
Various types of body fluids, cells, and tissues
Trace
10000+
Targeted + Untargeted
Relative quantitation + absolute quantitation
N:1(1%FDR)
6%
Mass Spectrometry
Applicable sample types
Sample amounts
Proteomics
Post-Translation Modification
Metabolomics
Lipidomics
Depth of testing
Capability of testing
Quantitative Analysis
Specificity
Reproducibility(CV)
Various types of body fluids, cells, and tissues
Low
8000+
Untargeted
Relative quantitation
N:1(1%FDR)
15%
Immuno method
Applicable sample types
Sample amounts
Proteomics
Post-Translation Modification
Metabolomics
Lipidomics
Depth of testing
Capability of testing
Quantitative Analysis
Specificity
Reproducibility(CV)
Plasma
Low
3000+
Targeted
Relative quantitation
2:1(5-10%FDR)
5-10%
Aptamer method
Applicable sample types
Sample amounts
Proteomics
Post-Translation Modification
Metabolomics
Lipidomics
Depth of testing
Capability of testing
Quantitative Analysis
Specificity
Reproducibility(CV)
Plasma
Low
7000+
Targeted
Relative quantitation
1:1(5-10%FDR)
5-10%

Untangle the Phenomics

Based on the qPharos™ technology and qULTRA® platform, we provide the products and services of full workflow solution for precision diagnosis and therapy, while congregating the databases of pathologies, potential biomarkers, and population phenotypical information, and exploring the phenotype-based clinical relevance through AI modeling.

· Research on clinical cohort studies

· Research on innovative drugs

· Translation of biomarkers